We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$5.58B
AUM Growth
-$2.21B
Cap. Flow
-$1.68B
Cap. Flow %
-30.12%
Top 10 Hldgs %
58.92%
Holding
80
New
11
Increased
25
Reduced
9
Closed
15

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$313M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$153M
3
VST icon
Vistra
VST
+$141M
4
NFE icon
New Fortress Energy
NFE
+$115M
5
MCY icon
Mercury Insurance
MCY
+$98.2M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$251M
2
UAL icon
United Airlines
UAL
+$96.7M
3
FLR icon
Fluor
FLR
+$65.3M
4
DAL icon
Delta Air Lines
DAL
+$49M
5
PARA
Paramount Global Class B
PARA
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 37.06%
2 Utilities 27.45%
3 Energy 10.46%
4 Financials 7.97%
5 Technology 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OFIX icon
26
Orthofix Medical
OFIX
$424M
$60.3M 1.08%
3,694,946
– –
DOLE icon
27
Dole
DOLE
$1.23B
$60M 1.08%
4,155,656
-1,044,344
-20% -$14.4M
HRTX icon
28
Heron Therapeutics
HRTX
$64.7M
$58.8M 1.05%
26,713,503
– –
ADEA icon
29
Adeia
ADEA
$3.1B
$57.3M 1.03%
4,335,131
-304,878
-7% -$4.24M
WBA
30
DELISTED
Walgreens Boots Alliance
WBA
$55.9M 1%
5,007,592
+1,907,592
+62% +$20.7M
ZYME icon
31
Zymeworks
ZYME
$1.77B
$51.7M 0.93%
4,338,444
+421,113
+11% +$5.74M
MD icon
32
Pediatrix Medical
MD
$2.15B
$45.4M 0.81%
3,133,299
-15,141
-0.5% -$215K
DK icon
33
Delek US
DK
$4.12B
$40.5M 0.73%
2,687,449
+87,449
+3% +$1.51M
LBTYK icon
34
Liberty Global Class C
LBTYK
$3.46B
$39.4M 0.71%
3,293,518
+201,637
+7% +$2.43M
PLAB icon
35
Photronics
PLAB
$1.97B
$38.7M 0.69%
1,862,737
+547,831
+42% +$12.2M
SIMO icon
36
Silicon Motion
SIMO
$8.18B
$35.4M 0.64%
700,882
+114,368
+19% +$6.19M
MREO
37
Mereo BioPharma
MREO
$48.3M
$34.4M 0.62%
15,307,347
– –
INDV icon
38
Indivior Pharmaceuticals
INDV
$4.57B
$33.6M 0.6%
3,530,039
+2,170,039
+160% +$22.8M
XPER icon
39
Xperi
XPER
$321M
$32M 0.57%
4,143,744
– –
TRVI icon
40
Trevi Therapeutics
TRVI
$2.53B
$28.5M 0.51%
4,538,535
+333,406
+8% +$1.59M
CNNE icon
41
Cannae Holdings
CNNE
$651M
$27.3M 0.49%
1,490,248
+60,000
+4% +$1.13M
IAS
42
DELISTED
Integral Ad Science
IAS
$25.5M 0.46%
3,166,949
+1,193,079
+60% +$11.9M
MATV icon
43
Mativ Holdings
MATV
$690M
$24.9M 0.45%
4,000,000
– –
FNA
44
DELISTED
Paragon 28, Inc.
FNA
$24.5M 0.44%
+1,879,635
New +$23.4M
GEO icon
45
The GEO Group
GEO
$4.14B
$19.7M 0.35%
+675,891
New +$19.4M
TSAT icon
46
Telesat
TSAT
$934M
$16.2M 0.29%
859,512
-100,252
-10% -$1.91M
EMBC icon
47
Embecta
EMBC
$269M
$13.9M 0.25%
1,087,654
+2,125
+0.2% +$34K
TH icon
48
Target Hospitality
TH
$1.61B
$13.2M 0.24%
2,000,000
+1,147,495
+135% +$9.21M
SPRY icon
49
ARS Pharmaceuticals
SPRY
$601M
$12.9M 0.23%
+1,029,101
New +$12.4M
SCPH
50
DELISTED
scPharmaceuticals
SCPH
$12.6M 0.23%
4,775,000
– –
1
2
3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2025 Portfolio in Review

As of Q1 2025, Rubric Capital Management (New York) held 80 positions worth $5.58B, down 28% from $7.79B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Rubric Capital Management (New York) withdrew a net $1.68B in Q1 2025, closing 15 positions and reducing 9 holdings. Its most notable exit was Viatris, an estimated $251M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 28% a quarter earlier, followed by Utilities and Energy.

Against the trend, Rubric Capital Management (New York) opened a new position in FTAI Aviation worth $294M.

  • Rubric Capital Management (New York)'s largest Q1 2025 buy was FTAI Aviation: 2,645,000 shares worth $294M.
  • Rubric Capital Management (New York) added most to Teva Pharmaceuticals in Q1 2025, an estimated $153M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2025 reduction was Roivant Sciences, cutting an estimated $24.1M.
  • Rubric Capital Management (New York) fully exited Viatris in Q1 2025, selling an estimated $251M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 59% of its $5.58B portfolio in Q1 2025.
  • Rubric Capital Management (New York) opened 11 new positions and closed 15 in Q1 2025.
  • Rubric Capital Management (New York)'s portfolio value fell 28% quarter-over-quarter to $5.58B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2025, filed 14 May 2025.